# Study to Investigate Safety, Absorption, Elimination, and Drug Effect of BAY2327949 in Participants With Different Renal Function Status

> **NCT04004195** · PHASE1 · COMPLETED · sponsor: **Bayer** · enrollment: 32 (actual)

## Conditions studied

- Pharmacokinetics

## Interventions

- **DRUG:** BAY2327949

## Key facts

- **NCT ID:** NCT04004195
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-10
- **Primary completion:** 2020-02-07
- **Final completion:** 2020-06-04
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2020-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04004195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04004195, "Study to Investigate Safety, Absorption, Elimination, and Drug Effect of BAY2327949 in Participants With Different Renal Function Status". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04004195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*